Yifei Sun

Dr. Yifei Sun


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2025 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
YSYifei Sun
Yifei Sun
MHMohammad Hamo
Mohammad Hamo
TATravis Atchley
Travis Atchley
JMJames M. Markert
James M. Markert
BNBurt Nabors
Burt Nabors
DEDagoberto Estevez-Ordonez
Dagoberto Estevez-Ordonez
Purpose: Glioblastoma is the most common primary brain malignancy and carries significant mortality. Preclinical studies have highlighted the efficacy of antidepressant therapy in inhibiting glioblastoma progression; however, real-world evidence remains conflicting. We sought to investigate the impact of different commonly utilized antidepressant therapies on survival in patients with glioblastoma. Methods: In total, 1464 consecutive patients with glioblastoma treated at a single institution from 2008 to 2023 were included for analysis. Multivariate cox regression analysis with antidepressant usage modeled as a time varying covariate was used to assess the effect of antidepressants while controlling for a priori selected clinical variables with known relevance to survival. Results: The median age at diagnosis was 62 (IQR 52–70) years with a median overall survival of 13.8 months. Of the cohort, 44% utilized antidepressants after diagnosis, with SSRIs as the most common class utilized (26%). The median duration of any antidepressant therapy was 111 (IQR 9-303) days. In a time varying, multivariate cox regression, usage of SSRIs (HR 1.4, 95%CI 1.21–1.62), SNRIs (HR 1.33, 95%CI 1.03–1.72), serotonin modulators (HR 1.61, 95%CI 1.40–1.86), and atypical antidepressants (HR 1.7, 95%CI 1.28–2.26) were associated with worse survival. Amongst SSRIs, only escitalopram (HR 1.33, 95%CI 1.10–1.60) and citalopram (HR 1.31, 95%CI 1.01–1.70) were associated with worse survival. Conclusions: Antidepressant therapy is associated with worse survival in patients with glioblastoma after adjusting for known factors with relevance to survival. Clinicians should consider the risks and benefits of prescribing antidepressants in patients with glioblastoma. Further evidence is necessary to better understand the impact of antidepressant therapy in glioblastoma survival.

5 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YSYifei Sun
Yifei Sun
HRHariteja Ramapuram
Hariteja Ramapuram
RRRiyaz Razi
Riyaz Razi
MHMohammad Hamo
Mohammad Hamo
SHSasha Howell
Sasha Howell
JGJake Godzik
Jake Godzik
Background/Objectives: Adult Spinal Deformity (ASD) is a pathologic malalignment of the spine that can lead to significant reductions in quality of life, functional limitations, and increased morbidity. While poor mental health is commonly observed among patients undergoing ASD surgery, its impact on surgical outcomes remains poorly understood. We conducted a systematic review and meta-analysis to examine the association between preoperative mental health and outcomes following surgical correction for ASD. Methods: A comprehensive search of MEDLINE, Embase, Web of Science, and Scopus was performed from inception to April 2025 to identify studies investigating the relationship between preoperative mental health and postoperative health-related quality of life outcomes or complications. Data was pooled using a restricted maximum likelihood (REML) random-effects model. Heterogeneity was assessed using Cochran’s Q statistic, and between-study variance was reported as τ2. Study quality was assessed with the Newcastle–Ottawa Scale, and risk of bias was evaluated using the ROBINS-I tool. Results: Twenty-four studies comprising a total of 248,427 patients met inclusion criteria. In pooled analyses, patients with poor preoperative mental health showed comparable improvements in health-related quality of life measures after surgery (standardized mean difference [SMD] −0.04, 95% CI −0.30 to 0.22; I2 = 91.5%, τ2 = 0.42) and in pain scores (SMD −0.15, 95% CI −0.42 to 0.11; I2 = 71.8%, τ2 = 0.09). However, patients with poor mental health had significantly higher odds of postoperative complications (odds ratio [OR] 1.44, 95% CI 1.23 to 1.67; I2 = 97.4%, τ2 = 0.08). These patients also demonstrated worse preoperative disease severity (SMD –0.94, 95% CI −1.41 to −0.47; I2 = 95.5%, τ2 = 1.64) and worse postoperative disease severity (SMD –0.34, 95% CI −0.44 to −0.25; I2 = 48.9%, τ2 = 0.03). Conclusions: While patients with poor preoperative mental health have a greater disease severity both before and after ASD surgery, they appear to experience comparable benefits from surgical intervention compared to those without. Recognizing and managing mental health may be useful in preoperative management of ASD patients. Further prospective studies to further elucidate these associations are necessary.

1 October 2026 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
YSYifei Sun
Yifei Sun
HRHariteja Ramapuram
Hariteja Ramapuram
BBBryant Barrentine
Bryant Barrentine
GTGarrett W. Thrash
Garrett W. Thrash
MHMohammad Hamo
Mohammad Hamo
DEDagoberto Estevez-Ordonez
Dagoberto Estevez-Ordonez
Background and objectives: Endoscopic transsphenoidal surgery is a common modality of pituitary adenoma resection. Recent evidence has suggested that socioeconomic disparities exist in outcomes of these operations. However, there exists limited evidence regarding the association between neighborhood socioeconomic disadvantage and outcomes following pituitary adenoma resection utilizing a transsphenoidal approach. We sought to investigate the impact of neighborhood disadvantage on outcomes following transsphenoidal pituitary adenoma resection. Methods: We retrospectively reviewed all adult patients at a single institution from 2012 to 2024 who underwent endoscopic transsphenoidal resection of pituitary adenomas. Patient addresses underwent geospatial analysis and Area Deprivation Index (ADI) was extracted, with patients in the top 90th percentile defined as having high socioeconomic deprivation. Univariable comparison and logistic regressions were utilized to assess the relationship between socioeconomic factors and length of stay, readmissions, and endocrine outcomes. Results: In total, 756 patients [median age 56 years (Interquartile range [IQR] 44–66)] met the inclusion criteria. The median ADI of the cohort was 74 (IQR 53–87). Patients who had high neighborhood disadvantage had larger tumor volumes compared to white patients at presentation (5.0 cm 3 vs 3.9 cm 3 , p = .01). Upon multivariable logistic regression, high neighborhood disadvantage (OR 3.51, 95%CI 1.53–7.98), postoperative hyponatremia (OR 3.87, 95% CI 1.88–8.24), postoperative diabetes insipidus (OR 5.7, 95%CI 2.73–12.4), and being uninsured (OR 4.31, 95%CI 1.05–15.8) were found to be associated with increased odds of prolonged length of stay. Being uninsured was also associated with delayed postoperative hyponatremia (OR 5.38, 95%CI 1.25–19.9), while delayed hyponatremia was associated with increased odds of 30-day readmission (OR 3.35, 95% CI 1.19–8.67). Conclusions: We present the first study reporting the effect of neighborhood-level socioeconomic status on outcomes following transsphenoidal pituitary adenoma resection. Socioeconomic status plays a complex role in surgical outcomes. Further research should focus on underlying drivers of disparities in outcomes in this population.